Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.

about

Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues Beyond Trisomy 21: Additional Chromosomal Anomalies Detected through Routine Aneuploidy Screening.

P2860

Q26764809-37827ECC-BBD1-428B-9A96-F8820DF29A95 Q35667283-1F908A80-B48D-414E-9E53-790A5BC85D2F

P2860

Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.

Item

http://www.wikidata.org/entity/Q38125511

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.

@en

type

Item

label

Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.

@en

prefLabel

Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.

@en

P1476

Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.

@en

P2093

Jon Hyett

http://www.w3.org/2001/XMLSchema#string

Lisa Hui

http://www.w3.org/2001/XMLSchema#string

P2860

Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci

DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.

DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.

Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.

Rapid clearance of fetal DNA from maternal plasma

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.

Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies.

Circulating fetal DNA: its origin and diagnostic potential-a review.

Nuchal translucency-based Down syndrome screening: barriers to implementation.

Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.

P304

416-424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJO.12117

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

254259964

http://www.w3.org/2001/XMLSchema#string

P698

23902297

http://www.w3.org/2001/XMLSchema#string

P921

Australia

Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.

about

P2860

P2860

Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921